Amalia Gastaldelli is Director of Research at the Institute of Clinical Physiology of National Research Council in Pisa, Italy, where she leads the Cardiometabolic Risk Group. She is also Adjunct Professor at UT Health San Antonio, TX, USA and at the Sant’Anna School in Pisa. Her research focuses on the pathophysiology of metabolic diseases, particularly MASLD, obesity, and type 2 diabetes, with emphasis on metabolic fluxes and hormone action. She is President of the European MASLD Study Group (EASD) and of EGIR-European Group for Insulin Resistance affiliated to EASD. She has served on international committees for clinical guidelines on MASLD/NAFLD and diabetes (EASL–EASD–EASO; IDF).